StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Jay Thakkar, ICICI Securities

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byJay Thakkar, ICICI SecuritiesHorizon: NA (inferred 1 year)7 Jul 2026via Business Today

Entry₹1,364Inferred
Target₹1,500
Total upside +9.97% (call closed)
Stop loss₹1,280-6.16% risk
Exit₹1,2809 Jul 2026, 12:07 pm
Stop-loss hit-6.16%
Follow Jay Thakkar for new callsGet alertsWatch DRREDDY for new buy/sell callsGet alertsSee 19 active Long-term calls on DRREDDYSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 9 Jul 2026
4 supporting2 opposing
Supports the BUY call (4)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·29 Jun · 1w ago

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·22 Jun · 2w ago

Dr. Reddy's Laboratories Limited announced the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif®, in the United States.

NSE · Press Release·13 Jun · 4w ago

(opens in new tab)

Dr. Reddy's Laboratories Ltd. has launched Bosutinib Tablets 400mg.

BSE · Company Update·13 Jun · 4w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (2)

3 other SEBI-registered advisors have active long-term SELL calls on this stock, with 2 issued in the last 14 days

Advisor consensus · same horizon·9 Jul · today

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·15 Apr · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Jay Thakkar, ICICI Securities

Every call and its outcome